Danaher Corporation DPO Ratio 2011-2026 | DHR

Annual DPO Ratio Danaher Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
65.4	66.4	67.1	77.2	88.1	66.3	69.7	71.2	67.7	71.8	76.3	72.3	70.9	63.8	65.6

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
88.1	63.8	70.7

Quarterly DPO Ratio Danaher Corporation

2025-Q1	2024-Q4	2024-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
71.1	-	-	-	-	71.9	75.3	-	65.2	73.4	80.9	-	70.3	76.5	85.6	-	71.4	70.5	73.6	-	72.3	72.2	71.7	-	69.2	67.9	73	-	73.4	72.8	74.7	-	97	80.7	79.4	-	74.9	73	74.6	-	72.3	72.4	71.6	-	66	64.2	65.1	-	57.4	75.5	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
97	57.4	73.1

DPO Ratio of other stocks in the Diagnostics research industry

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	120	-	-6.23 %	$ 30.6 M	Germany
ICON Public Limited Company ICLR	6.52	$ 98.33	0.9 %	$ 8.11 B	Irlanda
Akumin AKU	21.3	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	112	-	-6.19 %	$ 10.5 M	USA
Charles River Laboratories International CRL	24.5	$ 155.46	1.83 %	$ 7.71 B	USA
Bioventus BVS	35.1	$ 8.62	0.23 %	$ 574 M	USA
DexCom DXCM	67.7	$ 64.24	-1.56 %	$ 25.1 B	USA
Oxford Immunotec Global PLC OXFD	45.8	-	-	$ 562 M	Britain
Castle Biosciences CSTL	52	$ 25.56	0.95 %	$ 710 M	USA
CareDx, Inc CDNA	44.2	$ 17.01	3.4 %	$ 906 M	USA
Accelerate Diagnostics AXDX	125	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	49.2	$ 103.57	0.29 %	$ 19.5 B	USA
Guardant Health GH	48.6	$ 85.49	1.75 %	$ 10.7 B	USA
Global Cord Blood Corporation CO	17.7	-	-	$ 399 M	China
Fluidigm Corporation FLDM	61.4	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	780	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	43.5	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	34.9	$ 14.77	0.61 %	$ 447 M	USA
PRA Health Sciences, Inc. PRAH	8.98	-	-	$ 10.7 B	USA
Anixa Biosciences ANIX	1.29 K	$ 2.83	-1.05 %	$ 91.8 K	USA
IQVIA Holdings IQV	126	$ 164.72	1.1 %	$ 28.3 B	USA
Biocept BIOC	56.3	-	-13.05 %	$ 7.29 M	USA
Heska Corporation HSKA	39.7	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	112	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	56.3	$ 118.94	2.92 %	$ 18.9 B	USA
Quest Diagnostics Incorporated DGX	14.7	$ 199.7	-0.46 %	$ 22.2 B	USA
QIAGEN N.V. QGEN	50	-	-	$ 10.6 B	Niderland
Agilent Technologies A	50.1	$ 111.51	-0.06 %	$ 33.9 B	USA
BioNano Genomics BNGO	104	$ 1.11	-0.89 %	$ 1.41 M	USA
DarioHealth Corp. DRIO	43.9	$ 9.0	-0.99 %	$ 255 M	Israel
Neogen Corporation NEOG	62.7	$ 9.09	-2.78 %	$ 1.97 B	USA
National Research Corporation NRC	10.1	$ 16.52	0.12 %	$ 370 M	USA
Chembio Diagnostics CEMI	52.5	-	0.22 %	$ 16.8 M	USA
Pacific Biosciences of California PACB	59.7	$ 1.33	4.72 %	$ 399 M	USA
Co-Diagnostics CODX	106	-	-	$ 79.8 M	USA
Medpace Holdings MEDP	13.3	$ 450.41	1.48 %	$ 13 B	USA
DermTech DMTK	47.4	-	-11.32 %	$ 2.94 M	USA
Mettler-Toledo International MTD	53.4	$ 1 173.74	0.49 %	$ 24.2 B	Schweiz
Personalis PSNL	67.3	$ 6.72	1.97 %	$ 398 M	USA
NeoGenomics NEO	19.7	$ 7.88	-1.25 %	$ 1.01 B	USA
Enzo Biochem ENZ	52.3	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	17.9	$ 187.85	-1.29 %	$ 18.5 B	USA
Sotera Health Company SHC	46.9	$ 13.42	0.71 %	$ 3.81 B	USA
Invitae Corporation NVTA	69	-	-	$ 21.2 M	USA
OPKO Health OPK	43.1	$ 1.19	2.59 %	$ 826 M	USA